Literature DB >> 16557556

Nitration of cardiac proteins is associated with abnormal cardiac chronotropic responses in rats with biliary cirrhosis.

Ali R Mani1, Silvia Ippolito, Richard Ollosson, Kevin P Moore.   

Abstract

Acceleration of the heart rate in response to catecholamines is impaired in cirrhosis. In this study, we tested the hypothesis that increased formation of reactive nitrogen species in biliary cirrhosis causes nitration of cardiac proteins and leads to impaired chronotropic function. Bile duct-ligated (rats with cirrhosis) or sham-operated rats were injected daily with either saline, N(G)-L-nitro-arginine methyl ester (L-NAME), or N-acetylcysteine for 7 days from week 3 to week 4 after surgery. Cardiac chronotropic responsiveness to beta-adrenergic stimulation was assessed in vitro using spontaneous beating isolated atria. Nitration of cardiac proteins was measured by mass spectrometry and located by immunogold electron microscopy. Marked impairment of chronotropic responses of isolated atria to isoproterenol was seen in rats with cirrhosis, which normalized after the administration of N-acetylcysteine or L-NAME. The levels of protein-bound nitrotyrosine in atrial tissue increased from 16 +/- 1 to 23 +/- 3 pg/microg tyrosine in rats with cirrhosis, and decreased to 15 +/- 1 and 17 +/- 1 pg/microg after treatment with L-NAME and N-acetylcysteine, respectively (P < .05). Immunogold electron microscopy demonstrated increased nitration of mitochondrial proteins in the atria of rats with cirrhosis. The plasma nitrite/nitrate levels were elevated in rats with biliary cirrhosis, and decreased after administration of L-NAME but were unchanged by N-acetylcysteine. In conclusion, abnormal cardiac chronotropic function in cirrhosis is associated with increased nitration of cardiac proteins. Two independent treatments (N-acetylcysteine and L-NAME) that decrease nitration of cardiac proteins led to normalization of cardiac responses. Nitration of critical proteins in cardiac tissue may lead to abnormal cardiac function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16557556     DOI: 10.1002/hep.21115

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  14 in total

1.  Fas Receptor Activation by Endogenous Opioids Is A New Mechanism for Cardiomyopathy in Cirrhotic Rats.

Authors:  Ata Abbasi; Negar Faramarzi; Mohsen Khosravi; Fatemeh Yazarloo; Mohammad Amin Abbasi; Ahmad R Dehpour; Issa Jahanzad
Journal:  J Clin Exp Hepatol       Date:  2016-10-17

Review 2.  Nature and Implications of Oxidative and Nitrosative Stresses in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2016-07-13       Impact factor: 3.199

Review 3.  Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects.

Authors:  Søren Møller; Jens H Henriksen; Flemming Bendtsen
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

4.  Hyperammonemia results in reduced muscle function independent of muscle mass.

Authors:  John McDaniel; Gangarao Davuluri; Elizabeth Ann Hill; Michelle Moyer; Ashok Runkana; Richard Prayson; Erik van Lunteren; Srinivasan Dasarathy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-12-03       Impact factor: 4.052

5.  Decreased heart rate variability in patients with cirrhosis relates to the presence and degree of hepatic encephalopathy.

Authors:  Ali R Mani; Sara Montagnese; Clive D Jackson; Christopher W Jenkins; Ian M Head; Robert C Stephens; Kevin P Moore; Marsha Y Morgan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-11-20       Impact factor: 4.052

6.  Contribution of mammalian target of rapamycin in the pathophysiology of cirrhotic cardiomyopathy.

Authors:  Seyed Soheil Saeedi Saravi; Mahmoud Ghazi-Khansari; Shahram Ejtemaei Mehr; Maliheh Nobakht; Seyyedeh Elaheh Mousavi; Ahmad Reza Dehpour
Journal:  World J Gastroenterol       Date:  2016-05-21       Impact factor: 5.742

Review 7.  Cirrhotic cardiomyopathy.

Authors:  Luis Ruiz-del-Árbol; Regina Serradilla
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

8.  The end-organ impairment in liver cirrhosis: appointments for critical care.

Authors:  Antonio Figueiredo; Francisco Romero-Bermejo; Rui Perdigoto; Paulo Marcelino
Journal:  Crit Care Res Pract       Date:  2012-05-16

9.  Opioid receptors blockade modulates apoptosis in a rat model of cirrhotic cardiomyopathy.

Authors:  Ata Abbasi; Adel Joharimoqaddam; Negar Faramarzi; Mohsen Khosravi; Issa Jahanzad; Ahmad R Dehpour
Journal:  Ann Med Health Sci Res       Date:  2014-05

10.  The metabolism and de-bromination of bromotyrosine in vivo.

Authors:  Ali R Mani; José C Moreno; Theo J Visser; Kevin P Moore
Journal:  Free Radic Biol Med       Date:  2015-12-02       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.